Another important mutation, the anaplastic lymphoma kinase (ALK) translocation, is responsible for approximately 3–5 % of non-small-cell lung cancer (NSCLC) and is found predominately in adenocarcinomas [14]. The gene discussed is ALK; the disease is adenocarcinoma.